Lichen International Limited LICN
Company Overview
Lichen International Limited, an investment holding company, provides financial and taxation, education support, and software and maintenance services in the People's Republic of China. The company offers financial and taxation-related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation services; and education support services, including marketing, operational, and technical support, as well as the sale of teaching and learning materials. It also provides software and maintenance services, including the sale of financial and taxation analysis software, and financial and taxation training software, as well as offers software installation, training, and after-sales technical and maintenance support services. The company serves listed companies, state-owned enterprises, government authorities, and other business enterprises, including small and medium-sized enterprises. The company was formerly known as Lichen China Limited and changed its name to Lichen International Limited in March 2025. Lichen International Limited was incorporated in 2016 and is based in Xiamen, China.
Recent Developments
- Dec 2025 Revenue of $24.52M (-40.9% YoY); net profit $-21.96M.
- Trailing 12 Months Year-on-year growth — revenue -56.1%.
- 5-Year Trend Long-term compounding — revenue CAGR -10.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -10.15% |
| 1 Year: | -56.10% |
Stock Price Performance
| 1 Year: | -72.79% |
| 6 Months: | -62.86% |
| 3 Months: | -35.00% |
| 1 Month: | -3.31% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)44.30 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Revenue declined at -10.2% CAGR over 5 years.
- Trading 86.4% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Industrials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | LICN Lichen International Limited | 1.17 | -0.28 | $19.10M | 0.00% | -20.32% | -29.82% | -10.15% | - |
| 2 | SPCX Space Exploration Technologies Corp. R3KAIDEFENCE | 153.47 | -139.52 | $1.16T | 0.00% | -3.22% | -11.95% | 34.08% | -3.34% |
| 3 | CAT Caterpillar Inc. SPXR3K | 822.48 | 35.47 | $378.07B | 0.79% | 17.98% | 56.97% | 2.29% | 5.24% |
| 4 | GE GE Aerospace SPXR3KDEFENCE | 334.91 | 39.40 | $347.49B | 0.60% | 9.52% | 48.23% | -7.42% | -5.36% |
| 5 | RTX RTX Corporation SPXR3KDEFENCE | 198.81 | 35.06 | $267.95B | 1.51% | 8.28% | 12.27% | 2.61% | 2.62% |
| 6 | GEV GE Vernova Inc. SPXR3KAI | 971.31 | 27.86 | $258.69B | 0.22% | 6.30% | 82.58% | 8.68% | - |
| 7 | DE Deere & Company SPXR3K | 680.73 | 37.88 | $183.54B | 0.95% | 12.53% | 18.24% | 3.43% | 5.10% |
| 8 | UNP Union Pacific Corporation SPXR3K | 288.45 | 23.38 | $171.36B | 2.01% | 15.22% | 39.70% | 2.30% | 7.77% |
| 9 | BA The Boeing Company SPXR3KDEFENCE | 210.73 | 75.80 | $166.43B | 0.00% | -9.01% | - | 1.67% | -3.28% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 33.80M | 39.76M | 41.48M | 24.52M |
| Cost of Revenue | - | 13.61M | 15.44M | 15.80M | 15.38M |
| Gross Profit | - | 20.19M | 24.32M | 25.67M | 9.14M |
| Operating Expenses | - | 9.54M | 12.06M | 30.23M | 23.54M |
| Operating Income | - | 10.65M | 12.26M | -4.55M | -14.41M |
| EBITDA | - | 13.33M | 15.18M | -1.68M | -10.26M |
| Interest Expense | - | - | - | - | - |
| Pretax Income | - | 10.74M | 11.59M | -4.17M | -21.79M |
| Tax Provision | - | 2.92M | 3.25M | 1.95M | 0 |
| Net Income | - | 7.82M | 8.34M | -6.14M | -21.96M |
| Diluted EPS | 63.86 | 54.39 | 63.96 | -34.79 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 46.52M | 65.55M | 79.84M | 75.57M |
| Current Assets | - | 27.27M | 40.13M | 34.01M | 36.17M |
| Cash & Equivalents | - | 22.60M | 25.86M | 26.71M | 26.91M |
| Inventory | - | 127.00K | 87.00K | 67.00K | 0 |
| Receivables | - | 3.12M | 3.66M | 3.55M | 1.97M |
| Total Liabilities | - | 5.42M | 4.12M | 4.28M | 5.02M |
| Current Liabilities | - | 5.23M | 4.09M | 4.27M | 4.68M |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 272.00K | 129.00K | 61.00K | 554.00K |
| Total Equity | - | 41.11M | 61.42M | 73.18M | 70.55M |
| Shares Outstanding | - | 132.50K | 132.50K | 435.50K | 16.33M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 10.77M | 557.00K | -5.57M | -17.85M |
| Investing Cash Flow | - | -2.84M | -9.87M | -9.89M | -5.48M |
| Financing Cash Flow | - | -327.00K | 14.10M | 13.09M | 23.61M |
| Capital Expenditure | -28.00K | -2.84M | -9.87M | -5.93M | - |
| Free Cash Flow | - | 7.92M | -9.31M | -11.51M | -17.85M |
| Net Change in Cash | - | 7.60M | 4.79M | -2.37M | 285.00K |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 59.7% | 61.2% | 61.9% | 37.3% |
| Operating Margin % | - | 31.5% | 30.8% | -11.0% | -58.8% |
| Net Margin % | - | 23.1% | 21.0% | -14.8% | -89.6% |
| ROE % | - | 19.0% | 13.6% | -8.4% | -31.1% |
| ROCE % | - | 25.8% | 19.9% | -6.0% | -20.3% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | UBS Group AG | 0.83% | 135.17K | $145.98K |
| 2 | Virtu Financial LLC | 0.20% | 31.66K | $34.19K |
| 3 | Caitong International Asset Management Co., Ltd | - | 1 | $1 |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for LICN
Gapping stocks in Thursday's session - ChartMill
<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxNU0kyUkxRNVRJNzFaMGdGb3JLczFXS1l4YUdWMUdjSHZMcjR5bE1LNGpEN240SzR6UlFYNjE5V0ZWQWVVUFdIZ096NDJ4UHFuRkJRTjMyZ2d6VS04R1R2bndiclFyUUtJaUFaRDZCZU5rMzdXd1prbXVBaGVYYWdfcmRVb2tmbVA1eHJHSm…
LICN - Finviz
<a href="https://news.google.com/rss/articles/CBMiRkFVX3lxTE5fTDlPX2RnajJRZGg3X3VILXZQVWdxWTdLX3RZZlBrdUxjTDZwcFBtQVA3NWUyZVNNOTY0ZWZiWDl0QVpkUEE?oc=5" target="_blank">LICN</a> <font color="#6f6f6f">Finviz</font>…
LICN Stock Plunges In Back‑To‑Back Heavy Selling - StocksToTrade
<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxPMzJvQmRlUTRkQnZoNXhEWHJSVGE2cS1zQ0g2ZTBWMXYtLUp3Rkc0bWg4S0xReE5kYkttc2k0SXpCbm8ydm5qUG5xMFNiYWVOUHl5cjJMNXJhZG9hNjJuV3VyaUt4VkxiMjFGOVFxcXVqOVRZb2pUNG5mTVZod2w2WkRpdC1xYVp3?oc=5"…
Can Lichen International (NASDAQ:LICN) Afford To Invest In Growth? - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxPSkVoVzQ0UzRLMkxzWXZzT3RxMUpCWndmSV9ZbEtKOGlUWHJjUzJnMEVXb05EZEJpS2lULVBsbVpQZklxNXJQc0o3REx3Vk5hckNCUWNNQ0JnOVgzTExvNXktM0o2eGV5WXhSNTlhbVlXem02V2ZHZGNzeDZmRk81aVhRNUgyRndOVXpGU2…
Can Lichen International (NASDAQ:LICN) Afford To Invest In Growth? - webull.com
<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTE1ZTmdleEdKNzNoRG9YM01SNUZzVXdrTjdPeVBJN0c2Q2hjdjFwc3kybWhYTEhYY09taVlDSE1YelZVbi13bk9OYThuWlpuRGFPX1lTdDFrQ0w?oc=5" target="_blank">Can Lichen International (NASDAQ:LICN) Afford To…
What's going on in today's pre-market session - ChartMill
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxNUGtDeFNhN0VLdU1kQ1NtVzNuZUdfTVg5UXdZdElicGtsdHRONE0xYUdBbERibUhpTEowd0dER1ZLZGphbVFORkhOY2t5Ym5oU1U5QXZFenEtT3lnZDNFLVpkdHhsdEFJclgwYklkVV9PZmZhYjg2MmNtT0o2THd5aHBwQ0FRbGdRMExTNG…
LICN — Frequently Asked Questions
What is the current share price of Lichen International Limited (LICN)?
As of 2026-09-19 21:16 PDT, Lichen International Limited (LICN) trades at $1.17 on NasdaqCM. Its 52-week range is $0.84 to $8.63.
What is the market capitalisation of LICN?
Lichen International Limited (LICN) has a market capitalisation of $19.10M on NasdaqCM.
What is the P/E ratio of LICN?
LICN trades at a trailing price-to-earnings (P/E) ratio of -0.28. The industry average P/E is 26.00. Its price-to-book (P/B) ratio is 0.25.
What is the return on equity (ROE) of LICN?
LICN has a return on equity (ROE) of -29.82%. Its return on capital employed (ROCE) is -20.32%.
Is LICN a good stock to buy?
This page provides a data-driven analysis of Lichen International Limited (LICN), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.